
OrganiGram Holdings Inc
TSX:OGI

OrganiGram Holdings Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.42
3.1
|
Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does OrganiGram Holdings Inc hold over its rivals?
What risks and challenges
does OrganiGram Holdings Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of OrganiGram Holdings Inc.
Provide an overview of the primary business activities
of OrganiGram Holdings Inc.
What unique competitive advantages
does OrganiGram Holdings Inc hold over its rivals?
What risks and challenges
does OrganiGram Holdings Inc face in the near future?
Summarize the latest earnings call
of OrganiGram Holdings Inc.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for OrganiGram Holdings Inc.
Provide P/S
for OrganiGram Holdings Inc.
Provide P/E
for OrganiGram Holdings Inc.
Provide P/OCF
for OrganiGram Holdings Inc.
Provide P/FCFE
for OrganiGram Holdings Inc.
Provide P/B
for OrganiGram Holdings Inc.
Provide EV/S
for OrganiGram Holdings Inc.
Provide EV/GP
for OrganiGram Holdings Inc.
Provide EV/EBITDA
for OrganiGram Holdings Inc.
Provide EV/EBIT
for OrganiGram Holdings Inc.
Provide EV/OCF
for OrganiGram Holdings Inc.
Provide EV/FCFF
for OrganiGram Holdings Inc.
Provide EV/IC
for OrganiGram Holdings Inc.
Show me price targets
for OrganiGram Holdings Inc made by professional analysts.
What are the Revenue projections
for OrganiGram Holdings Inc?
How accurate were the past Revenue estimates
for OrganiGram Holdings Inc?
What are the Net Income projections
for OrganiGram Holdings Inc?
How accurate were the past Net Income estimates
for OrganiGram Holdings Inc?
What are the EPS projections
for OrganiGram Holdings Inc?
How accurate were the past EPS estimates
for OrganiGram Holdings Inc?
What are the EBIT projections
for OrganiGram Holdings Inc?
How accurate were the past EBIT estimates
for OrganiGram Holdings Inc?
Compare the revenue forecasts
for OrganiGram Holdings Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of OrganiGram Holdings Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of OrganiGram Holdings Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of OrganiGram Holdings Inc compared to its peers.
Compare the P/E ratios
of OrganiGram Holdings Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing OrganiGram Holdings Inc with its peers.
Analyze the financial leverage
of OrganiGram Holdings Inc compared to its main competitors.
Show all profitability ratios
for OrganiGram Holdings Inc.
Provide ROE
for OrganiGram Holdings Inc.
Provide ROA
for OrganiGram Holdings Inc.
Provide ROIC
for OrganiGram Holdings Inc.
Provide ROCE
for OrganiGram Holdings Inc.
Provide Gross Margin
for OrganiGram Holdings Inc.
Provide Operating Margin
for OrganiGram Holdings Inc.
Provide Net Margin
for OrganiGram Holdings Inc.
Provide FCF Margin
for OrganiGram Holdings Inc.
Show all solvency ratios
for OrganiGram Holdings Inc.
Provide D/E Ratio
for OrganiGram Holdings Inc.
Provide D/A Ratio
for OrganiGram Holdings Inc.
Provide Interest Coverage Ratio
for OrganiGram Holdings Inc.
Provide Altman Z-Score Ratio
for OrganiGram Holdings Inc.
Provide Quick Ratio
for OrganiGram Holdings Inc.
Provide Current Ratio
for OrganiGram Holdings Inc.
Provide Cash Ratio
for OrganiGram Holdings Inc.
What is the historical Revenue growth
over the last 5 years for OrganiGram Holdings Inc?
What is the historical Net Income growth
over the last 5 years for OrganiGram Holdings Inc?
What is the current Free Cash Flow
of OrganiGram Holdings Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for OrganiGram Holdings Inc.
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
CA |
![]() |
OrganiGram Holdings Inc
TSX:OGI
|
182.9m CAD | -4.8 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
776.2B USD | 22 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 1 026 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
394B USD | 6.6 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK | 8.8 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
236.5B CHF | 5.8 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
177B GBP | 55.4 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
225.9B USD | 4.8 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
199.7B CHF | 6.1 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
167.6B USD | 111.2 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
142.3B USD | 4.2 |
|
CA |
![]() |
OrganiGram Holdings Inc
TSX:OGI
|
Average EV/GP:
125.1
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
22
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
1 026
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
6.6
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
8.8
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
5.8
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
55.4
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
4.8
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
6.1
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
111.2
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
4.2
|
|
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.